Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation

Clinical trial NCT00185757 · COMPLETED

Trial details

NCT number: NCT00185757
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma Blood and Marrow Transplant (BMT)

Start date: 2004-06-01
Primary completion: 2012-12-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.